Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07422090Recruiting

Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions

Role: collaborator

NCT06975631Not ApplicableCompleted

Post-market Study on TrHCROSS® in Knee Osteoarthritis After a Single Injection

Role: collaborator

NCT05192564Not ApplicableUnknown

Exercise and Vestibular Hypofunction

Role: collaborator

NCT05066581Not ApplicableCompleted

Vitoria Sleep Smart City: Interactive Intervention for Sleep Improvement

Role: collaborator

All 4 trials loaded